Many of us have already 10x'd our money on MindMedicine (MMED / MMEDF):  should we take our profits now or hold for the next 10 years? Brom dives deep into this topic and looks at questions like:

• Will the Nasdaq uplisting happen? 
• Is MindMed's drug development pipeline strong?
• Why is MindMed associated with sketchy pump and dump groups like Departures Capital and Market Jar Media? 
• Do they have a way to capitalize on their research?
• WTF is Kevin O'Leary doing in a drug company? 
• Why did JR Rahn sell his shares? 
• Does MindMed Founder and CEO JR Rahn have the right qualifications? 
• Is MindMed's team a winning team? 

Watch on YouTube

https://www.youtube.com/playlist?list=PLSojjMXxr79FMrXF5ocZ5Qy5uEQ78FQJG

Listen to this video on Spotify:

https://open.spotify.com/show/1nVnMFaYNmln6fwk63B9kd

Listen to this video on other Podcast Platforms:

https://anchor.fm/brom1

Brom on Instagram:  

https://www.instagram.com/brom_qr/channel/ 

Brom on Twitter:

https://twitter.com/therealbrom

Brom's personal website:

https://brom.ai